¤ OpenAccess: Hybrid

This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)

Phoebe Rich,Melinda Gooderham,Debabrata Bandyopadhyay,Joana Gonçalves,Robert M. Day,Rongdean Chen,Jeffrey Crowley

Apremilast

Medicine

Psoriasis

2016

Cite this:

Generate Citation

“Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)” is a paper by Phoebe Rich Melinda Gooderham Debabrata Bandyopadhyay Joana Gonçalves Robert M. Day Rongdean Chen Jeffrey Crowley published in 2016. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.